FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape Read more
ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment Read more
Indian pharma industry profitability improves as pricing environment eases: Equirus Capital Read more
Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData Read more